Consort Medical plc (LON:CSRT) has received an average rating of “Buy” from the seven research firms that are presently covering the stock. Two analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 12-month price objective among brokerages that have issued ratings on the stock in the last year is GBX 1,149.67 ($14.26).

Separately, Canaccord Genuity restated a “buy” rating and issued a GBX 1,300 ($16.13) price objective on shares of Consort Medical plc in a research report on Thursday, August 11th.

Shares of Consort Medical plc (LON:CSRT) traded down 1.19% during midday trading on Monday, hitting GBX 1081.00. 7,759 shares of the company traded hands. Consort Medical plc has a 12-month low of GBX 935.00 and a 12-month high of GBX 1,180.00. The stock’s market capitalization is GBX 527.84 million. The stock’s 50-day moving average is GBX 1,117.70 and its 200 day moving average is GBX 1,045.56.

TRADEMARK VIOLATION NOTICE: “Consort Medical plc (CSRT) Given Average Rating of “Buy” by Brokerages” was first published by The Cerbat Gem and is the propert of of The Cerbat Gem. If you are accessing this piece on another domain, it was copied illegally and reposted in violation of United States & international copyright legislation. The legal version of this piece can be accessed at

In other Consort Medical plc news, insider Cotton,Richard purchased 1,382 shares of the stock in a transaction dated Monday, September 5th. The stock was bought at an average price of GBX 651 ($8.08) per share, for a total transaction of £8,996.82 ($11,160.92).

About Consort Medical plc

Consort Medical PLC is a contract development and manufacturing organization (CDMO). The Company’s principal activities include designing, development and manufacture of medical drug delivery devices and services for the pharmaceutical industry. The Company operates through two segments: Bespak and Aesica.

Receive News & Stock Ratings for Consort Medical plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Consort Medical plc and related stocks with our FREE daily email newsletter.